Kenvue Inc.
$17.32+0.99%(+$0.17)
TickerSpark Score
66/100
87
Valuation
85
Profitability
60
Growth
68
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KVUE research report →
52-Week Range32% of range
Low $14.02
Current $17.32
High $24.36
Companywww.kenvue.com
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.
- CEO
- Kirk L. Perry
- IPO
- 2023
- Employees
- 22,000
- HQ
- Summit, NJ, US
Price Chart
-28.22% · this period
Valuation
- Market Cap
- $33.25B
- P/E
- 20.48
- P/S
- 2.17
- P/B
- 3.13
- EV/EBITDA
- 12.54
- Div Yield
- 4.79%
Profitability
- Gross Margin
- 58.37%
- Op Margin
- 19.62%
- Net Margin
- 10.61%
- ROE
- 15.18%
- ROIC
- 9.76%
Growth & Income
- Revenue
- $15.12B · -2.14%
- Net Income
- $1.47B · 42.72%
- EPS
- $0.77 · 42.59%
- Op Income
- $2.70B
- FCF YoY
- 28.99%
Performance & Tape
- 52W High
- $24.36
- 52W Low
- $14.02
- 50D MA
- $17.42
- 200D MA
- $17.65
- Beta
- 0.52
- Avg Volume
- 24.01M
Get TickerSpark's AI analysis on KVUE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 8, 26 | Orlando Matthew | sell | 38,491.296 |
| Mar 30, 26 | Smith Jeffrey C | other | 1,331 |
| Mar 30, 26 | ALLISON RICHARD E JR | other | 1,331 |
| Mar 10, 26 | Stevens Meredith | other | 4,329.269 |
| Mar 10, 26 | Stevens Meredith | other | 840.351 |
| Mar 10, 26 | Stevens Meredith | other | 358 |
| Mar 10, 26 | Stevens Meredith | other | 1,738 |
| Mar 10, 26 | Stevens Meredith | other | 4,329.269 |
| Mar 10, 26 | Stevens Meredith | other | 840.351 |
| Mar 10, 26 | Alvarado Luani | other | 3,525.293 |
Our KVUE Coverage
We haven't published any research on KVUE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KVUE Report →